Pharmafile Logo
Pharmafocus logo
Advanced Search

osteoporosis

Showing 8 posts of 23 posts found.

Amgen image

Amgen files high earnings for Q1

April 22, 2015
Sales and Marketing AMG 334, Amgen, Corlanor, Kyprolis, Prolia, Q1, Xgeva, brodalumab, myeloma, osteoporosis

Amgen has boosted its first quarter profit by 51% due to surging drug sales and ongoing cuts that paved the …

News

UCB and Amgen’s osteoporosis drug shows promise

April 21, 2011
Research and Development Amgen, UCB, osteoporosis

Amgen and UCB have announced strong results from a phase II study of their new postmenopausal osteoporosis treatment. Most existing …

News

FDA warns of bisphosphonates fracture risk

October 20, 2010
Sales and Marketing Boniva, Fosamax, Reclast, actonel, bisphosphonates, osteoporosis

The FDA has ordered a label change for a number of osteoporosis drugs after concerns their long-term use raises the …

News

Trial shows long-term benefits of Novartis’ Aclasta

October 18, 2010
Research and Development, Sales and Marketing Novartis, aclasta, osteoporosis

Novartis has published new data at the annual meeting of the American Society for Bone and Mineral Research in Toronto …

News
NHS Direct

Digital Pharma: NHS Direct pilots online treatment aids

June 11, 2010
Medical Communications NHS, NHS Direct, osteoporosis, patient information, prostate cancer

NHS Direct is piloting online decision aids to help patients suffering from osteoporosis or prostate cancer make informed healthcare choices. …

News

Warner Chilcott gets Actonel lift

April 6, 2010
Sales and Marketing Sanofi, Warner Chilcott, actonel, osteoporosis

Warner Chilcott has assumed all commercial responsibility for its osteoporosis drug Actonel in the US. Sanofi-Aventis has agreed to pass …

News

Servier fails to overturn NICE osteoporotic guidance

February 2, 2010
Sales and Marketing NICE, Servier, osteoporosis

Servier’s challenge to NICE guidance on preventing osteoporotic fractures has proved unsuccessful, with the watchdog’s original decision still standing. This …

News

Osteoporosis drug Aclasta approved for use in men

October 2, 2008
Sales and Marketing Novartis, aclasta, osteoporosis

Osteoporosis treatment Aclasta has been approved for an extended indication in the European Union.Novartis’ once-yearly infusion has now been given …

News
The Gateway to Local Adoption Series

Latest content

Faron Pharmaceuticals appoints Heikki Jouttijärvi as Chief Technical Officer

April 2, 2026

Cambridge’s Grassroots Life Sciences Showcase Branches Out to Oxford & London

April 1, 2026

Doccla appoints Michael Macdonnell as Chief Strategy & Growth Officer and Deputy CEO

April 1, 2026

Bramacare launches new AI platform to improve eating disorder care

March 31, 2026

Doccla appoints Jonathan Serjeant as Chief Medical Officer

March 31, 2026